I-Ray

· Oraya Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for I-Ray, covering 2013-04-26 to 2013-04-26. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]

See pricing